<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-cancers-12-00713">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pujantell</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Franco</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Galván-Femenía</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Badia</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Castellví</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Garcia-Vidal</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Clotet</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>de Cid</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tural</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Martínez</surname>
    <given-names>M.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>ADAR1 affects HCV infection by modulating innate immune response</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>156</volume>
  <fpage>116</fpage>
  <lpage>127</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.05.012</pub-id>
  <?supplied-pmid 29906476?>
  <pub-id pub-id-type="pmid">29906476</pub-id>
 </element-citation>
</ref>
